December 3, 2023

Ottawa Canada will phase out about 13.6 million doses of Oxford AstraZeneca COVID-19 Vaccine because he could not find any recipient for it either at home or abroad.

Canada signed a contract with AstraZeneca in 2020 for 20 million doses of its vaccine, and 2.3 million Canadians received at least one dose of it, mostly between March and June 2021.

After concerns in the spring of 2021 about Rare but fatal blood clots of AstraZeneca, Canada, focused on using its abundant supply of mRNA vaccines from Pfizer-BioNTech and Moderna.

In July 2021, Canada promised to donate the rest of its purchased supplies, about 17.7 million doses. But in a statement on Tuesday, Health Canada said that despite efforts to honor that pledge, 13.6 million doses had expired and would have to be disposed of.

“Due to the limited demand for the vaccine and the recipient country’s challenges with regard to distribution and absorption, it has not been accepted,” the statement said.

The United States Supports Global Vaccine Distribution Efforts


In all, Canada has donated 8.9 million doses of the AstraZeneca vaccine — 4.8 million doses from its main supply and 4.1 million doses it has purchased from the vaccine. COVAX Vaccine Participation Program.

About 85% of Canadians are considered fully vaccinated, compared to 61% of the world’s population, and only 16% of people living in the world’s poorest countries.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *